SOCS3 and central nervous system cancer: GPM6B may promote the transformation of glioma stem cells and inhibit growth of glioma by suppressing Integrin β1–mediated regulation of β-catenin, while simultaneously reducing its own degradation through inhibition of the ubiquitinase SOCS3, thereby stabilizing its function in glioma.